Naschitz was a research advisor to fellow Carmit Avidan-Shpalter.
Naschitz, managing director and Partner at OrbiMed, has more than 15 years of international experience in health-care operations and investment.
She previously spent seven years with McKinsey & Company in London, where she was an associate partner, managing strategy and M&A projects for senior leadership of the world’s preeminent pharmaceutical and biotechnology companies. Naschitz led work that catalyzed pharmaceutical spinouts, resulting in the creation of two European biotech companies that subsequently completed IPOs for more than $1 billion. She then joined Apax Partners, where she focused on life sciences investments.
More recently Naschitz worked with investors and companies on transactions and corporate strategy. She has served as a director or advisor to the boards of multiple medical device and biopharmaceutical companies.
Naschitz holds an MBA from INSEAD and an LLB from Tel Aviv University.